tanshinone has been researched along with Hypertrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diel, P; Hegevoss, J; Kulling, SE; Ngueu, S; Soukup, ST; Zhao, P | 1 |
| Chung, LC; Hsieh, DJ; HsuanDay, C; Huang, CY; Jong, GP; Kuo, WW; Lai, CH; Pai, PY; Wang, HF; Weng, YS | 1 |
2 other study(ies) available for tanshinone and Hypertrophy
| Article | Year |
|---|---|
Anabolic effect of the traditional Chinese medicine compound tanshinone IIA on myotube hypertrophy is mediated by estrogen receptor.
Topics: Abietanes; Anabolic Agents; Androgen Receptor Antagonists; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Drugs, Chinese Herbal; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; HEK293 Cells; Humans; Hypertrophy; Muscle Fibers, Skeletal; Muscular Atrophy; Phytotherapy; Receptors, Estrogen; Salvia miltiorrhiza; Selective Estrogen Receptor Modulators | 2015 |
Tanshinone IIA Prevents Leu27IGF-II-Induced Cardiomyocyte Hypertrophy Mediated by Estrogen Receptor and Subsequent Akt Activation.
Topics: Abietanes; Animals; Calcineurin; Cardiotonic Agents; Cell Line; Cell Survival; Estradiol; Fulvestrant; Hypertrophy; Insulin-Like Growth Factor II; Myocytes, Cardiac; NFATC Transcription Factors; Phytotherapy; Proto-Oncogene Proteins c-akt; Rats; Receptor, IGF Type 2; Receptors, Estrogen; Salvia miltiorrhiza; Signal Transduction | 2015 |